Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
According to the study talked about in the video, curcumin and diet can slow the progression of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma. I don’t believe in diets.
Continue readingA beneficial effect of lenalidomide maintenance therapy on overall survival (of MM) in this setting has been inconsistent between individual studies. I have been on Revlimid for four years. Nothing has
Continue readingtreatment of MGUS/SMM patients with curcumin resulted in an improvement in markers of disease progression (i.e., free light-chain ratio (rFLC), paraprotein levels, percentage plasma cells) in some patients
Continue readingSerious adverse events were reported in 494 (45%) of 1097 patients receiving lenalidomide compared with 150 (17%) of 874 patients on observation. “Hi David- I was diagnosed with mm in sept. 2018
Continue reading“Our data suggest that arrhythmias after transplants are associated with significant morbidity and mortality. A prospective study of arrhythmia in the transplant setting is warranted…” You
Continue readingDespite the known limitations…conventional radiography (X-rays) still represents the reference standard for diagnostic testing due to its wide availability and low costs. Diagnostic testing is the
Continue reading“This study clearly shows that curcumin nanoparticles could deliver DOX efficiently…Surprisingly, extracellular alkalization induced a 2- to 3-fold increase in the efficacy of doxorubicin…” Before
Continue reading“As with MGRS, patients with smoldering myeloma (SMM) are asymptomatic but have higher MIg levels and BMPCs.” Hi David- I have been diagnosed with Smoldering Multiple Myeloma 3 months ago.
Continue readingThe article linked and excerpted below talks about a relapse in MM to be about the damage or risk of damage caused by disease to be the guiding factor when consider whether or not to actively treat you
Continue reading“Long-term Bone Marrow (LT-BM) injury is a common cancer treatment-related late effect caused by IR- and chemotherapy-induced damage to HSCs.” Conventional multiple myeloma treatment is fraught
Continue readingBalance Therapy for Quality of Life With Quantity of Life With the Newly Diagnosed Multiple Myeloma Patient. A “non-transplant eligible patient” is a patient who is too weak to take the standard-of-care,
Continue readingThe aim is to investigate retrospectively the association between vitamin B12 levels at the time of diagnosis and the complications including hypercalcemia and fractures in multiple myeloma patients. Hi
Continue reading